Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Mimedx Group (MDXG) EBIAT: 2011-2025

Historic EBIAT for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to $16.7 million.

  • Mimedx Group's EBIAT rose 106.89% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.8 million, marking a year-over-year decrease of 52.67%. This contributed to the annual value of $42.4 million for FY2024, which is 37.10% down from last year.
  • As of Q3 2025, Mimedx Group's EBIAT stood at $16.7 million, which was up 74.13% from $9.6 million recorded in Q2 2025.
  • Over the past 5 years, Mimedx Group's EBIAT peaked at $51.3 million during Q4 2023, and registered a low of -$10.9 million during Q2 2022.
  • Over the past 3 years, Mimedx Group's median EBIAT value was $9.3 million (recorded in 2023), while the average stood at $12.7 million.
  • As far as peak fluctuations go, Mimedx Group's EBIAT tumbled by 510.91% in 2022, and later surged by 12,488.41% in 2023.
  • Mimedx Group's EBIAT (Quarterly) stood at $199,000 in 2021, then plummeted by 308.04% to -$414,000 in 2022, then soared by 12,488.41% to $51.3 million in 2023, then slumped by 85.50% to $7.4 million in 2024, then soared by 106.89% to $16.7 million in 2025.
  • Its EBIAT was $16.7 million in Q3 2025, compared to $9.6 million in Q2 2025 and $7.0 million in Q1 2025.